AC-2020-12-1420.R1 – HIV care providers’ familiarity, concerns, and attitudes about HIV PrEP in Colombia: insights from the PrEP-Col-Study

References

• Anderson, P. L., Glidden, D. V., Liu, A., Buchbinder, S., Lama, J. R., Guanira, J. V., McMahan, V., Bushman, L. R., Casapía, M., Montoya-Herrera, O., Veloso, V. G., Mayer, K. H., Chariyalertsak, S., Schechter, M., Bekker, L.-G., Kallás, E. G., Grant, R. M., & iPrEx Study, T. (2012). Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine, 4(151), 151ra125–151ra125. https://doi.org/10.1126/scitranslmed.3004006
   PubMed Web of Science ®Google Scholar
• Barros, A. J. D., & Hirakata, V. N. (2003). Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Medical Research Methodology, 3(1), 21. https://doi.org/10.1186/1471-2288-3-21
   PubMedGoogle Scholar
• Blackstock, O. J., Moore, B. A., Berkenblit, G. V., Calabrese, S. K., Cunningham, C. O., Fiellin, D. A., Patel, V. V., Phillips, K. A., Tetrault, J. M., Shah, M., & Edelman, E. J. (2017). A cross-sectional online survey of HIV Pre-exposure prophylaxis adoption Among primary care physicians. Journal of General Internal Medicine, 32(1), 62–70. https://doi.org/10.1007/s11606-016-3903-z
   PubMed Web of Science ®Google Scholar
• Cimen, C., Emecen, A. N., & Barber, T. J. (2020). Attitude of infectious diseases physicians in Turkey about HIV pre-exposure prophylaxis: Results of an online survey. International Journal of STD & AIDS, 31(7), 665–670. https://doi.org/10.1177/0956462420921080
   PubMed Web of Science ®Google Scholar
• Coutinho, L. M., Scazufca, M., & Menezes, P. R. (2008). Métodos para estimar razão de prevalência em estudos de corte transversal. Revista de Saúde Pública, 42(6), 992–998. https://doi.org/10.1590/S0034-89102008000600003
   PubMed Web of Science ®Google Scholar
• Desai, M., Gafos, M., Dolling, D., McCormack, S., Nardone, A., & study, P. (2016). Healthcare providers’ knowledge of, attitudes to and practice of pre-exposure prophylaxis for HIV infection. HIV Medicine, 17(2), 133–142. https://doi.org/10.1111/hiv.12285
   PubMed Web of Science ®Google Scholar
• Di Biagio, A., Riccardi, N., Signori, A., Maserati, R., Nozza, S., Gori, A., Bonora, S., Borderi, M., Ripamonti, D., Rossi, M. C., Orofino, G., Quirino, T., Nunnari, G., Celesia, B. M., Martini, S., Sagnelli, C., Mazzola, G., Colletti, P., Bartolozzi, D., … Lo Caputo, S. (2017). PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians’ attitudes towards using antiretrovirals to prevent HIV infection. PLoS One, 12(7), e0181433. https://doi.org/10.1371/journal.pone.0181433
   PubMed Web of Science ®Google Scholar
• Fonner, V. A., Dalglish, S. L., Kennedy, C. E., Baggaley, R., O'Reilly, K. R., Koechlin, F. M., Rodolph, M., Hodges-Mameletzis, I., & Grant, R. M. (2016). Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. Aids (london, England), 30(12), 1973–1983. https://doi.org/10.1097/QAD.0000000000001145
   PubMed Web of Science ®Google Scholar
• Hayes, R., Schmidt, A. J., Pharris, A., Azad, Y., Brown, A. E., Weatherburn, P., Hickson, F., Delpech, V., Noori, T., & The, E. D. D. M. N. (2019). Estimating the ‘PrEP gap': How implementation and access to PrEP differ between countries in Europe and Central Asia in 2019. Eurosurveillance, 24(41), pii = 1900598. https://doi.org/10.2807/1560-7917.ES.2019.24.41.1900598
   Web of Science ®Google Scholar
• Henderson, J. L., MacKay, S., & Peterson-Badali, M. (2006). Closing the research-practice gap: Factors affecting adoption and implementation of a children's mental health program. Journal of Clinical Child & Adolescent Psychology, 35(1), 2–12. https://doi.org/10.1207/s15374424jccp3501_1
   PubMed Web of Science ®Google Scholar
• Huijg, J. M., Gebhardt, W. A., Dusseldorp, E., Verheijden, M. W., van der Zouwe, N., Middelkoop, B. J. C., & Crone, M. R. (2014). Measuring determinants of implementation behavior: Psychometric properties of a questionnaire based on the theoretical domains framework. Implementation Science, 9(1), 33. https://doi.org/10.1186/1748-5908-9-33
   PubMedGoogle Scholar
• Krakower, D., Ware, N., Mitty, J. A., Maloney, K., & Mayer, K. H. (2014). Hiv providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: A qualitative study. AIDS and Behavior, 18(9), 1712–1721. https://doi.org/10.1007/s10461-014-0839-3
   PubMed Web of Science ®Google Scholar
• Minsalud. (2019). Acta No 01 de 2019. Sesion Ordinaria. 28(29), 29, 30 y 31 de Enero de 2019. https://www.invima.gov.co/documents/20143/1194435/Acta-No-01-de-2019-SEMNNIMB.pdf/02fa2ab2-d796-a3af-c3da-4f8a600e55b1?t=1559854654834
   Google Scholar
• Montana, J. F., Ferreira, G., Cunha, C. L. F., de Queiroz, A. A. R., Fernandes, W. A. A., Polaro, S. H. I., Goncalves, L. H. T., Couto, D. C. C., Gir, E., Reis, R. K., Sorensen, W., & Botelho, E. P. (2021). The HIV epidemic in Colombia: Spatial and temporal trends analysis. BMC Public Health, 21(1), 178. https://doi.org/10.1186/s12889-021-10196-y
   PubMed Web of Science ®Google Scholar
• OMS. (2017). Herramienta de implementación de la OMS para la profilaxis previa a la exposición de la infección por VIH. Retrieved 15/05/2020 from https://www.who.int/hiv/pub/prep/prep-implementation-tool/en/
   Google Scholar
• ONUSIDA. (2015). Estrategia ONUSIDA 2016-2021. Accion Acelerada para Acabar con el SIDA. https://www.unaids.org/sites/default/files/media_asset/UNAIDS-strategy-2016-2021_es.pdf
   Google Scholar
• OPS. (2019). OPS y Secretaría de Salud lanzan plan piloto para método de prevención de VIH en población vulnerable. Organizacion Panamericana de la Salud. Retrieved November 2 from https://www.paho.org/col/index.php?option=com_content&view=article&id=3275:ops-y-secretaria-de-salud-lanzan-plan-piloto-para-metodo-de-prevencion-de-vih-en-poblacion-vulnerable&Itemid=487
   Google Scholar
• Pleuhs, B., Quinn, K. G., Walsh, J. L., Petroll, A. E., & John, S. A. (2020). Health care provider barriers to HIV Pre-exposure prophylaxis in the United States: A systematic review. AIDS Patient Care and STDs, 34(3), 111–123. https://doi.org/10.1089/apc.2019.0189
   PubMed Web of Science ®Google Scholar
• Plomer, A. S., McCool-Myers, M., & Apfelbacher, C. (2020). Perspectives on HIV PrEP care in Germany: Qualitative insights from primary care physicians and specialists. AIDS Care, 32(8), 994–1000. https://doi.org/10.1080/09540121.2020.1778626
   PubMed Web of Science ®Google Scholar
• Reyniers, T., Vuylsteke, B., Pirotte, B., Hoornenborg, E., Bil, J. P., Wouters, K., Laga, M., & Nostlinger, C. (2018). Physicians’ preparedness for pre-exposure prophylaxis: Results of an online survey in Belgium. Sexual Health, 15(6), 606–611. https://doi.org/10.1071/SH18072
   PubMed Web of Science ®Google Scholar
• Sanchez-Rubio Ferrandez, J., Martinez Sesmero, J. M., Navarro Aznarez, H., Fernandez Espinola, S., Escobar Rodriguez, I., & Ventura Cerda, J. M. (2016). Perceptions about HIV pre-exposure prophylaxis among healthcare professionals in Spain (PERPPRES study). Farmacia Hospitalaria, 40(4), 287–301. https://doi.org/10.7399/fh.2016.40.4.10489
   PubMedGoogle Scholar
• Sharma, M., Wilton, J., Senn, H., Fowler, S., & Tan, D. H. (2014). Preparing for PrEP: Perceptions and readiness of Canadian physicians for the implementation of HIV pre-exposure prophylaxis. PLoS One, 9(8), e105283. https://doi.org/10.1371/journal.pone.0105283
   PubMed Web of Science ®Google Scholar
• Sinno, J., Doria, N., Cochkanoff, N., Numer, M., Neyedli, H., & Tan, D. (2021). Attitudes and practices of a sample of nova scotian physicians for the implementation of HIV Pre-exposure prophylaxis. HIV AIDS (Auckl), 13, 157–170. https://doi.org/10.2147/HIV.S287201
   PubMedGoogle Scholar
• Tan, D. H. S., Hull, M. W., Yoong, D., Tremblay, C., O'Byrne, P., Thomas, R., Kille, J., Baril, J. G., Cox, J., Giguere, P., Harris, M., Hughes, C., MacPherson, P., O'Donnell, S., Reimer, J., Singh, A., Barrett, L., Bogoch, I., Jollimore, J., … Biomedical, H. I. V. P. W. G. o. t. C. C. H. I. V. T. N. (2017). Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis. Canadian Medical Association Journal, 189(47), E1448–E1458. https://doi.org/10.1503/cmaj.170494
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2018). Country factsheets. Colombia, 2018. UNAIDS.
   Google Scholar
• WHO. (2015a). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV; 2015.
   Google Scholar
• WHO. (2015b). Pre-Exposure Prophylaxis. WHO Expands Recommendatin on Oral Pre-Exposure Prophylaxis of HIV Infection. https://apps.who.int/iris/bitstream/handle/10665/197906/WHO_HIV_2015.48_eng.pdf?sequence=1
   Google Scholar